Neonatal Jaundice Therapy Apparatus
Brand BIOBASE
Product origin CHINA
Delivery time Within 7 days
Supply capacity Factory Direct Supply
Model BHZ-003
Introduction
The neonatal jaundice therapy apparatus is widely used in the clinical treatment of neonatal hyperbilirubinemia. Bilirubin is photosensitive; under the combined effect of light and oxygen, fat-soluble bilirubin is oxidized into water-soluble metabolites, which can be excreted from the body via bile or urine, thereby effectively reducing the concentration of serum unconjugated bilirubin.
Download
Application:
This device is intended for the clinical treatment of neonatal jaundice. It is designed to be positioned beneath the neonate to deliver upward-directed phototherapy.
Technical Parameters：
Model | BHZ-003 |
Light Source | LED |
Dominant Wavelength of Blue Light | 425~475nm |
LED Lifetime | 50000h |
Product Service Life | 6 years |
Timing Operating Modes | 3H, 9H, 12H |
Irradiance Levels | 3-grade adjustable(H,M,L) |
Effective Treatment Area | 400* 240mm |
Total Bilirubin Phototherapy Irradiance | H: 1.8mW/cm² ± 0.5mW/cm² M: 1.5mW/cm² ± 0.5mW/cm² L: 1mW/cm² ± 0.5mW/cm² |
Irradiance Uniformity (for Bilirubin Phototherapy) | ≥0.4 |
Infrared Radiation | ≤10mW/cm² within the effective irradiation area |
Ultraviolet Radiation | ≤0.00001mW/cm² within the effective irradiation area (180nm < λ ≤ 400nm) |
Noise | ≤45dB(A) |
Power Supply | AC100~240V; 50/60Hz |
External Size(W*D*H) | 475* 277*6mm |
Packing Size(W*D*H) | 600*315*70mm |
Net Weight | 1kg |
Gross Weight | 2kg |
